MoHFW proposes extended deadline for compliance with revised Schedule M for small and medium scale manufacturers: public comments invited on draft Notification by Lexplosion | Jan 10, 2025 | Central, OPS, PharmaceuticalsIn view of several representations to extend the timeline to enable small and medium scale... Read More
MoHFW issues Drugs and Cosmetics (Amendment) Rules, 2020 effective 01.03.2020.; introduces new responsibilities for marketers of drugs by comtideging1971 | Feb 20, 2020 | OPS, Pharmaceuticals, statesThe Ministry of Health and Family Welfare has, in a Notification dated 11th February, 2020, issued... Read More
MoHFW issues Medical Devices (Amendment) Rules, 2020 effective 1st April, 2020; registration of medical devices to be voluntary till 1.10.2021, post which mandatory registration will be required by comtideging1971 | Feb 17, 2020 | Healthcare, Hospitality, OPS, statesThe Ministry of Health and Family Welfare (“Ministry”) has, in a Notification dated 11th February,... Read More
MOHFW extends timeline within which all implantable medical devices / CT scan / MRI equipment’s / X-ray machines / Dialysis machines, etc. will be considered as ‘Drugs’ till 01.04.2021 by comtideging1971 | Jan 2, 2020 | HealthcareThe Ministry of Health and Family Welfare (“Ministry”) has extended the timeline within which the... Read More
MOHFW proposes to exempt drugs supplied to Health Functionaries like Community Health Officers, Nurses etc. attached to Primary Health Centres/ Health & Wellness Centres from certain provisions of the Drugs & Cosmetics Act by comtideging1971 | Nov 11, 2019 | OPS, Pharmaceuticals, statesIn a notification dated 6th November 2019 the Ministry of Health and Family Welfare has issued a... Read More
